Premium
MK‐0966, a cyclooxygenase‐2 (COX‐2) specific inhibitor, had no effect on the anti‐platelet activity of low‐dose aspirin (ASA) measured by serum thromboxane B 2 (TXB 2 ) production and platelet aggregation
Author(s) -
Greenberg H.E.,
Gillen L.P.,
Dorval E.P.,
Wildonger L.,
Larson P.,
Huntington M.,
Wong P.,
Gottesdiener K.,
Waldman S.A.
Publication year - 1999
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1016/s0009-9236(99)80184-2
Subject(s) - cyclooxygenase , aspirin , pharmacology , platelet , thromboxane , platelet aggregation , thromboxane b2 , thromboxane a2 , medicine , chemistry , biochemistry , enzyme
Clinical Pharmacology & Therapeutics (1999) 65 , 163–163; doi: